Doxorubicin Hydrochloride 2 mg/mL

Doxorubicin Hydrochloride 2 mg/mL is an injectable solution used for various medical treatments. This multi-dose vial is manufactured by Hikma Pharmaceuticals USA Inc. and is administered intravenously.

Doxorubicin Hydrochloride is primarily used in cancer treatments. It is often prescribed for conditions like breast cancer, lymphoma, and other types of tumors. The medication works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients and healthcare providers often seek information on what Doxorubicin Hydrochloride is used for, particularly in the context of intravenous administration.

Common effects of Doxorubicin Hydrochloride may include nausea, fatigue, and hair loss. Some patients might experience more severe reactions, such as heart-related issues or changes in blood cell counts. It is important to monitor these effects closely and consult with a healthcare provider if any concerns arise.

Handling Doxorubicin Hydrochloride requires careful precautions due to its potent nature. The medication should be stored properly and administered by trained healthcare professionals. Patients should be aware of potential side effects and discuss any pre-existing conditions with their doctor before starting treatment.

Doxorubicin Hydrochloride can interact with other medications, including certain antibiotics, heart medications, and other chemotherapy drugs. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of the treatment.